Whole-exome sequencing of ovarian and endometrial cancer cell lines
Genomic DNA was extracted using the DNeasy Blood &amp; Tissue Kit (Qiagen). Library preparation used the Agilent SureSelect Human All Exon V7 Kit (Agilent Technologies) with 150 bp paired-end sequencing on NovaSeq Xplus (Illumina). This study is to identify the baseline genomic determinants underlying DHX9 inhibitor response in ovarian and endometrial cancer cell lines.